GSK

Showing 15 posts of 760 posts found.

GSK appoint HSBC director Iain Mackay as new CFO

August 7, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GSK, GlaxoSmithKline, Iain Mckay, cfo, hsbc

British pharma giant GlaxoSmithKline have appointed HSBC Group Finance Director, Iain Mackay, as its new Chief Financial Officer. The move …

top_10_image

Top Ten most popular articles on Pharmafile.com this week

August 3, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EMA, EU, GSK, Sanofi, brexit, pharmafile, top 10

While average temperatures dropped to a comfortable 22 degrees, the past week has put the EMA in a sticky position …

Chittagong, Bangladesh in the rain

GSK announces closure of Bangladesh facilities

July 30, 2018
Manufacturing and Production Bangladesh, Chittagong, GSK, closure, manufacturing

The British multinational GlaxoSmithKline has announced the closure of its facilities in Bangladesh after more than six decades of operation …

gsk_boronia_australia

GSK forges $300m partnership with 23andMe to boost preclinical R&D

July 26, 2018
Research and Development 23andME, GSK, GlaxoSmithKline, collaboration, genetics, pharma

In a bid to supercharge its drug discovery efforts, GlaxoSmithKline has sealed a $300 million deal with personal genomics and …

25870220061_456a80df07_z

Employees protest against shutting down of GSK facility in Bangladesh

July 24, 2018
Manufacturing and Production Bangladesh, GSK, manufacturing, protest, union

Employees of the British multinational GlaxoSmithKline (GSK) have led a protest against the shutting down of manufacturing facilities in Bangladesh. …

mosquito-1016254_1280

First new treatment for reccurent malaria approved in over 60 years

July 23, 2018
Manufacturing and Production FDA, GSK, approval, malaria, p.vivax

The FDA has approved GSK’s Krintafel for the treatment of a recurring form of malaria in patients aged 16 and …

top_10_image

Top Ten most popular articles on Pharmafile.com this week

July 20, 2018
Medical Communications GSK, ICR, J&J, JJ, Novartis, Trump, brexit, top 10

As Brexit negotions have hit a stalemate this week, the United Kingdom’s exit from the European Union has hit the …

gsk_boronia_australia

GSK confirms £250m deal to sell experimental drug to Dermavent Sciences

July 13, 2018
Medical Communications Dermavent, GSK, Roivant, tapinarof

British company GlaxoSmithKline has announced that it will sell the rights to its experimental dermatology drug, tapinarof, to Roivant Sciences’ …

mylan_building

FDA knocks back Mylan’s Advair generic for second time

June 14, 2018
Sales and Marketing Advair, FDA, GSK, Mylan, pharma

The FDA has rejected Mylan’s generic version of GlaxoSmithKline’s Advair for the second time following its knockback last year, citing …

astrazeneca-sign

AZ’s hopes for Fasenra in COPD suffer terminal blow

May 30, 2018
Research and Development AstraZeneca, Fasenra, GSK, Nucala, biotech, drugs, pharma, pharmaceutical

It looked unlikely that Fasenra would achieve success in the chronic obstructive pulmonary disease (COPD) area, after it suffered in …

top_ten

Top Ten most popular articles on Pharmafile.com this week

May 11, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, EMA, GSK, J&J, JJ, Novartis, Shire, Takeda, Valeant, biotech, drugs, pharma, pharmaceutical

It’s been a week in which one of the largest pharmaceutical takeovers in history took place and yet it’s not …

AZ’s Fasenra stumbles in P3 for COPD

May 11, 2018
Medical Communications, Research and Development AstraZeneca, Fasenra, GSK, Nucala, biotech, drugs, pharma, pharmaceutical

AstraZeneca’s Fasenra arrived later on the scene than GSK rival med, Nucala, and so it needed to quickly rack up …

GSK’s CFO chooses to exit company

May 9, 2018
Medical Communications GSK, biotech, drugs, pharma, pharmaceutical

Simon Dingemans has been Chief Financial Officer at GSK since 2011 but has now chosen to retire from the position …

The Gateway to Local Adoption Series

Latest content